相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis
Gustavo Arruda Viani et al.
BRACHYTHERAPY (2021)
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost
Yasir Alayed et al.
RADIOTHERAPY AND ONCOLOGY (2021)
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
Thomas Reynaud et al.
BRACHYTHERAPY (2021)
HDR Prostate Brachytherapy
Juanita Crook et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Progress in Low Dose Rate Brachytherapy for Prostate Cancer
Patrick W. McLaughlin et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Prostate high dose -rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer
Zaid A. Siddiqui et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Permanent prostate brachytherapy monotherapy with I-125 for low- and intermediate-risk prostate cancer: Outcomes in 974 patients
David M. Routman et al.
BRACHYTHERAPY (2019)
Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
Justin Barnes et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)
Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series
Daniel Buergy et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2018)
Favorable Preliminary Outcomes for Men With Low- and Intermediate-risk Prostate Cancer Treated With 19-Gy Single-fraction High-dose-rate Brachytherapy
Daniel J. Krauss et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer
Peter Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial
T. Major et al.
BRACHYTHERAPY (2017)
High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results
Pedro J. Prada et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Permanent seed brachytherapy for clinically localized prostate cancer: Long-term outcomes in a 700 patient cohort
Evelyn Martinez et al.
BRACHYTHERAPY (2015)
Treatment technique evolution and dosimetry trends over seven years of low dose rate prostate brachytherapy at an Australian institution
Thomas P. Rutten et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2013)
High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: Treatment description and preliminary results
Pedro J. Prada et al.
BRACHYTHERAPY (2012)
DOSE ESCALATION IMPROVES CANCER-RELATED EVENTS AT 10 YEARS FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH HYPOFRACTIONATED HIGH-DOSE-RATE BOOST AND EXTERNAL BEAM RADIOTHERAPY
Alvaro A. Martinez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2007)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The radiobiology of prostate cancer including new aspects of fractionatedradiotherapy
JF Fowler
ACTA ONCOLOGICA (2005)
Is α/β for prostate tumors really low?
J Fowler et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report
AA Martinez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)